Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

ESPR holding history

Esperion Therapeutics, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ESPR overviewAll 13F holders of ESPRFull Q2 2026 holdings

Shares (Q2 2026)
1,030
Value
$3.25K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ESPR by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,030$3.25K<0.1%00.0%UnchangedHolders
Q1 20261,030$2.82K<0.1%−53−4.9%ReducedHolders
Q4 20251,083$4.01K<0.1%00.0%UnchangedHolders
Q3 20251,083$2.87K<0.1%00.0%UnchangedHolders
Q2 20251,083$1.07K<0.1%−97−8.2%ReducedHolders
Q1 20251,180$1.70K<0.1%+97+9.0%AddedHolders
Q4 20241,083$2.38K<0.1%00.0%UnchangedHolders
Q3 20241,083$1.79K<0.1%00.0%UnchangedHolders
Q2 20241,083$2.40K<0.1%00.0%UnchangedHolders
Q1 20241,083$2.90K<0.1%00.0%UnchangedHolders
Q4 20231,083$3.24K<0.1%00.0%UnchangedHolders
Q3 20231,083$1.06K<0.1%00.0%UnchangedHolders
Q2 20231,083$1.51K<0.1%−147−12.0%ReducedHolders
Q1 20231,230$1.96K<0.1%−2,509−67.1%ReducedHolders
Q4 20223,739$23.3K<0.1%−2,493−40.0%ReducedHolders
Q3 20226,232$42.0K<0.1%+584+10.3%AddedHolders
Q2 20225,648$36.0K<0.1%+1,156+25.7%AddedHolders
Q1 20224,492$21.0K<0.1%+3,198+247.1%AddedHolders
Q4 20211,294$6.00K<0.1%−3,279−71.7%ReducedHolders
Q3 20214,573$55.0K<0.1%−220−4.6%ReducedHolders
Q2 20214,793$101.0K<0.1%−650−11.9%ReducedHolders
Q1 20215,443$153.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.